Sign in
4

Changes in Ownership

BioStem Technologies, Inc. Filed Acc 0002147189-26-000006

Chief Financial Officer acquired 10,634 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
POE BRANDON Chief Financial Officer 2026-08-11 Option exercise +10,634 56,368 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
POE BRANDON Chief Financial Officer 2026-08-11 Option exercise · Restricted Stock Units −10,634 21,591 D: show line 2 in the form
Loading xslF345X06/ownership.xml…